Drug results: 1
ustekinumab | A humanized monoclonal antibody that binds to IL-12 and IL-23 and is used as a DERMATOLOGIC AGENT in the treatment of patients with plaque PSORIASIS who have not responded to other therapies. |
Citing DrugCentral © 2024. License